Cargando…

Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months’ antiretroviral therapy experience in Cameroon

INTRODUCTION: The current expansion of antiretroviral treatment (ART) in the developing world without routine virological monitoring still raises concerns on the outcome of the strategy in terms of virological success and drug resistance burden. We assessed the virological outcome and drug resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aghokeng, Avelin F, Kouanfack, Charles, Eymard-Duvernay, Sabrina, Butel, Christelle, Edoul, Ginette E, Laurent, Christian, Koulla-Shiro, Sinata, Delaporte, Eric, Mpoudi-Ngole, Eitel, Peeters, Martine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2013
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562358/ https://www.ncbi.nlm.nih.gov/pubmed/23374858 http://dx.doi.org/10.7448/IAS.16.1.18004

Ejemplares similares

Antiretroviral Drug Resistance and Routine Therapy, Cameroon
por: Laurent, Christian, et al.
Publicado: (2006)

Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
por: Aghokeng, Avelin F., et al.
Publicado: (2009)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets
por: Boullé, Charlotte, et al.
Publicado: (2016)

HIV and Hepatitis C Virus Coinfection, Cameroon
por: Laurent, Christian, et al.
Publicado: (2007)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
por: Liégeois, Florian, et al.
Publicado: (2020)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
por: Ciaffi, Laura, et al.
Publicado: (2015)

Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon
por: Mbougua, Jules B Tchatchueng, et al.
Publicado: (2010)

Commercial Logging and HIV Epidemic, Rural Equatorial Africa
por: Laurent, Christian, et al.
Publicado: (2004)

Genetic diversity of simian lentivirus in wild De Brazza’s monkeys (Cercopithecus neglectus) in Equatorial Africa
por: Aghokeng, Avelin F., et al.
Publicado: (2010)

Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon
por: Liégeois, Florian, et al.
Publicado: (2012)

New indicators for delay in initiation of antiretroviral treatment: estimates for Cameroon
por: Ndawinz, Jacques DA, et al.
Publicado: (2015)

Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance
por: Billong, Serge C., et al.
Publicado: (2013)

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
por: Temfack, Elvis, et al.
Publicado: (2018)

Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
por: Ndongo, Francis Ateba, et al.
Publicado: (2022)

Noninvasive western lowland gorilla's health monitoring: A decade of simian immunodeficiency virus surveillance in southern Cameroon
por: Villabona‐Arenas, Christian Julian, et al.
Publicado: (2018)

A randomized blinded controlled trial of mobile phone reminders on the follow-up medical care of HIV-exposed and HIV-infected children in Cameroon: study protocol (MORE CARE)
por: Bigna, Jean Joel R, et al.
Publicado: (2013)

Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms
por: Etienne, Lucie, et al.
Publicado: (2011)

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study
por: Kabore, Firmin Nongodo, et al.
Publicado: (2017)

Multiplex detection of antibodies to Chikungunya, O’nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo
por: Raulino, Raisa, et al.
Publicado: (2021)

Molecular Evidence for the Presence of Rickettsia Felis in the Feces of Wild-living African Apes
por: Keita, Alpha Kabinet, et al.
Publicado: (2013)

Dynamics of Antibodies to Ebolaviruses in an Eidolon helvum Bat Colony in Cameroon
por: Djomsi, Dowbiss Meta, et al.
Publicado: (2022)

Early Warning Indicators for HIV Drug Resistance in Cameroon during the Year 2010
por: Billong, Serge C., et al.
Publicado: (2012)

Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat
por: Peeters, Martine, et al.
Publicado: (2002)

Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015–2017
por: De Nys, Helene M., et al.
Publicado: (2018)

Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic
por: Tongo, Marcel, et al.
Publicado: (2013)

Factors associated with non-adherence to scheduled medical follow-up appointments among Cameroonian children requiring HIV care: a case-control analysis of the usual-care group in the MORE CARE trial
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Barriers to the implementation of mobile phone reminders in pediatric HIV care: a pre-trial analysis of the Cameroonian MORE CARE study
por: Bigna, Jean Joel R, et al.
Publicado: (2014)

Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study
por: Namme Luma, Henry, et al.
Publicado: (2012)

APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa
por: Kabore, Nongodo Firmin, et al.
Publicado: (2021)

Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon
por: Ndam, Nicaise Tuikue, et al.
Publicado: (2017)

Near full-length HIV type 1M genomic sequences from Cameroon : Evidence of early diverging under-sampled lineages in the country
por: Tongo, Marcel, et al.
Publicado: (2015)

Determinants of retention in care in an antiretroviral therapy (ART) program in urban Cameroon, 2003–2005
por: Tsague, Landry, et al.
Publicado: (2008)

Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count
por: Bigna, Jean Joel R., et al.
Publicado: (2016)

Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Douala, Cameroon: A Cross Sectional Study
por: Luma, Henry Namme, et al.
Publicado: (2013)

The predominance of Human Immunodeficiency Virus type 1 (HIV-1) circulating recombinant form 02 (CRF02_AG) in West Central Africa may be related to its replicative fitness
por: Njai, Harr F, et al.
Publicado: (2006)

Exposure to Nonhuman Primates in Rural Cameroon
por: Wolfe, Nathan D., et al.
Publicado: (2004)

Detection of DNA of filariae closely related to Mansonella perstans in faecal samples from wild non-human primates from Cameroon and Gabon
por: Gaillard, Colette Marie, et al.
Publicado: (2020)

Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon
por: Penda, Calixte Ida, et al.
Publicado: (2022)

Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon
por: Torimiro, Judith N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2s3eef8budleli5gooqvcg7d22